BECs from COPD patients showed upregulated mesenchymal markers, such as α-SMA, type I collagen, vimentin, and NADPH Oxidase 4 as well as a lower expression of epithelial markers, confirming an active EMT in these patients [174]. The gene discussed is ACTA1; the disease is chronic obstructive pulmonary disease.